Moleculin Biotech, Inc. (MBRX)

CIK 1659617 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Moleculin Biotech, Inc..

Recent SEC filings

FiledFormAccession number
Aug 31, 20268-K0001437749-26-029336
Aug 25, 2026SCHEDULE 13D0001437749-26-028927
Aug 25, 2026SCHEDULE 13D0001437749-26-028926
Aug 24, 2026DEFA14A0001437749-26-028842
Aug 24, 2026DEF 14A0001437749-26-028835
Aug 21, 2026424B50001437749-26-028751
Aug 14, 2026PRE 14A0001437749-26-028049
Aug 14, 20268-K0001437749-26-027835
Aug 13, 202610-Q0001437749-26-027688
Aug 10, 2026SCHEDULE 13G0001649553-26-000082
Aug 6, 2026SCHEDULE 13G0001213900-26-086246
Aug 5, 202640001437749-26-025929
Aug 5, 202640001437749-26-025927
Aug 5, 202640001437749-26-025928
Aug 3, 2026424B50001437749-26-025335
Aug 3, 20268-K0001437749-26-025474
Jul 31, 2026S-1/A0001437749-26-025130
Jul 31, 2026EFFECT9999999995-26-002515
Jul 31, 20268-K0001437749-26-025167
Jul 30, 2026S-1/A0001437749-26-025100
Jul 29, 2026S-10001437749-26-024774
Jun 30, 20268-K0001437749-26-022088
Jun 30, 20268-K0001437749-26-022087
Jun 24, 202640001437749-26-021612
Jun 24, 202640001437749-26-021611